{"disease":{"id":"diabetic-kidney-disease","name":"diabetic kidney disease","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":7},"drugs":{"marketed":[{"drug_id":"olmesartan","indication_name":"diabetic kidney disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"olmesartan medoxomil-hydrochlorothiazide","generic_name":"OLMESARTAN","company_name":"Cosette","drug_phase":"marketed","molecular_target":"","drug_class":"Thiazide Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":"Olmesartan works by blocking the action of a hormone that causes blood vessels to constrict, allowing blood vessels to relax and blood pressure to decrease."},{"drug_id":"hctz","indication_name":"diabetic kidney disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lisinopril/HCTZ","generic_name":"HCTZ","company_name":"Direct_Rx","drug_phase":"marketed","molecular_target":"","drug_class":"Thiazide Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00342927","title":"Family Investigation of Nephropathy and Diabetes (F.I.N.D.)","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT04802395","title":"Real World Evidence Clinical Utility Study of KidneyIntelX","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Renalytix AI, Inc.","has_results":false},{"nct_id":"NCT02545049","title":"Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":7352,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT05349955","title":"Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community","phase":"NA","overall_status":"RECRUITING","enrollment_count":5600,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT07032116","title":"YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":4472,"lead_sponsor_name":"Liu Hongfang","has_results":false},{"nct_id":"NCT03625648","title":"Pentoxifylline in Diabetic Kidney Disease","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2376,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT04960514","title":"Prospective Decision Impact Trial of KidneyIntelX","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Renalytix AI, Inc.","has_results":false},{"nct_id":"NCT03865914","title":"Correlation Study Between Clinical Phenotype and Pathology of Type 2 Diabetic Nephropathy","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT07348718","title":"Rubix LS Diabetic Kidney Disease (DKD) Registry Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Rubix LS","has_results":false},{"nct_id":"NCT05198284","title":"Prospective Decision Impact Clinical Utility Trial of KidneyIntelX","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Renalytix AI, Inc.","has_results":false},{"nct_id":"NCT05888909","title":"Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Nephropathy","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT05047263","title":"A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1584,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04791358","title":"Decision Impact Trial of KidneyIntelX","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Renalytix AI, Inc.","has_results":false},{"nct_id":"NCT03550443","title":"A Phase 3 Study of Bardoxolone Methyl in Patients With Diabetic Kidney Disease; AYAME Study","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":1323,"lead_sponsor_name":"Kyowa Kirin Co., Ltd.","has_results":false},{"nct_id":"NCT04612595","title":"The Association Between sUCR and the Survival in Patients With DKD","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Guangdong Provincial People's Hospital","has_results":false},{"nct_id":"NCT04976426","title":"Establishment and Clinical Validation of a New Technique for Early Diagnosis of Diabetic Nephropathy","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT03201406","title":"Retrospective Analysis of Renal Prognosis in Patients With Chronic Kidney Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":837,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT06833541","title":"Research on Gut Microbiota and Metabolomics in Diabetic Kidney Disease","phase":"","overall_status":"RECRUITING","enrollment_count":720,"lead_sponsor_name":"The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT04170543","title":"A Phase 2b Diabetic Kidney Disease Study","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":609,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT03716401","title":"Prognostic Imaging Biomarkers for Diabetic Kidney Disease","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"University of Leeds","has_results":false},{"nct_id":"NCT05025540","title":"Automatic Segmentation Ultrasound-based Radiomics Technology in Diabetic Kidney Disease","phase":"","overall_status":"COMPLETED","enrollment_count":499,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT04026165","title":"Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":384,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT05086549","title":"An Observation Study to Evaluate the Renoprotective Effect of Fimasartan in Patients With DKD and Proteinuria","phase":"","overall_status":"COMPLETED","enrollment_count":360,"lead_sponsor_name":"Boryung Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT04328181","title":"Comparison of Imaging Quality Between Spectral Photon Counting Computed Tomography (SPCCT) and Dual Energy Computed Tomography (DECT)","phase":"NA","overall_status":"RECRUITING","enrollment_count":339,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT01752985","title":"Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":319,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT05593575","title":"Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":305,"lead_sponsor_name":"Shanghai Pharmaceuticals Holding Co., Ltd","has_results":false},{"nct_id":"NCT04916132","title":"Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Herlev Hospital","has_results":false},{"nct_id":"NCT04176276","title":"Determining Serum and Urinary Levels of miRNA 192 and miRNA 25 in Patients With and Without Type 2 Diabetes.","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"University of Pisa","has_results":false},{"nct_id":"NCT06415214","title":"Efficacy and Safety of HRS-7535 Tablets in Adults With Diabetic Kidney Disease in Type 2 Diabetes","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":281,"lead_sponsor_name":"Shandong Suncadia Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT07271186","title":"Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":270,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT07352436","title":"Gut Microbiota and Serum Metabolites as Predictors of Glycemic Variability and Outcomes in Diabetic Kidney Disease","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":270,"lead_sponsor_name":"Eighth Affiliated Hospital, Sun Yat-sen University","has_results":false},{"nct_id":"NCT05514548","title":"Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":265,"lead_sponsor_name":"Inversago Pharma Inc.","has_results":false},{"nct_id":"NCT06049550","title":"The Influence of the Thickening of Bowman's Capsule on the Clinical Prognosis of Patients With Diabetic Kidney Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT06006689","title":"Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis)","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":228,"lead_sponsor_name":"Tasly Pharmaceutical Group Co., Ltd","has_results":false},{"nct_id":"NCT07034807","title":"YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study2","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":228,"lead_sponsor_name":"Liu Hongfang","has_results":false},{"nct_id":"NCT03164785","title":"Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":202,"lead_sponsor_name":"Second Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT07354958","title":"Impact of Diabetes-Related Metabolic Derangements on Clinical Outcomes in Hospitalized Patients With Chronic Kidney Disease","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT07444203","title":"Transformative Research in Diabetic Nephropathy 2.0","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT07459946","title":"Research on Innovative Traditional Chinese Medicine Diagnosis and Treatment Technologies for Diabetic Nephropathy Driven by Multi-Omics and Artificial Intelligence","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":198,"lead_sponsor_name":"Jiazhen Yin","has_results":false},{"nct_id":"NCT04977011","title":"Effectiveness of Music Intervention on Anxiety and Physiological Responses in Critical Ill Patient","phase":"NA","overall_status":"COMPLETED","enrollment_count":196,"lead_sponsor_name":"Min-Sheng General Hospital","has_results":false},{"nct_id":"NCT06962098","title":"Efficacy and Safety Study of Isuzinaxib in Subjects With DKD","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":186,"lead_sponsor_name":"Aptabio Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03184662","title":"Efficacy of a High-intensity Physical Activity Program on Renal Function in High Risk Patients With Type 2 Diabetes","phase":"NA","overall_status":"TERMINATED","enrollment_count":178,"lead_sponsor_name":"Poitiers University Hospital","has_results":false},{"nct_id":"NCT04942119","title":"Impact of Long-term Serum Magnesium and Potassium Levels Optimization and Multifactorial Adherence Intervention on the Progression of Diabetic Kidney Disease.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":160,"lead_sponsor_name":"United Arab Emirates University","has_results":false},{"nct_id":"NCT05759468","title":"NAD Augmentation in Diabetes Kidney Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":156,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT03412006","title":"A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY1142524 in Patients With Type II Diabetes and a Clinical Diagnosis of Diabetic Kidney Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT06452862","title":"Multimodal Magnetic Resonance Imaging in Evaluation of Diabetic Kidney Disease","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Shengjing Hospital","has_results":false},{"nct_id":"NCT04689074","title":"Establishment of the Human Intestinal and Salivary Microbiota Biobank - Kidney Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari","has_results":false},{"nct_id":"NCT01878045","title":"Mechanisms of Diabetic Kidney Disease in American Indians","phase":"","overall_status":"SUSPENDED","enrollment_count":141,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT03449199","title":"Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"Teijin America, Inc.","has_results":true},{"nct_id":"NCT06948292","title":"Role of QRX-3 in Chronic Kidney Disease Patients in Outpatients Clinics","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":127,"lead_sponsor_name":"Ebima Clifford Okundaye","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}